Tag: IVC filter
First US patient enrolled in Gore Viafort vascular stent pivotal study
W L Gore & Associates (Gore) has announced that the first US patient has been enrolled in a prospective, non-randomised, multicentre, single-arm study with...
New study indicates cost-effectiveness of Denali IVC filter over Option device
Tilting or hooking occurred significantly less often in the process of retrieving the Denali inferior vena cava (IVC) filter (BD) than with the Option...
FDA clears CavaClear IVC filter removal laser sheath
Royal Philips has announced US Food and Drug Administration (FDA) de novo clearance for the Philips inferior vena cava (IVC) filter removal laser sheath—CavaClear—to...
Philips receives FDA Breakthrough Device designation for laser-assisted IVC filter removal...
Royal Philips today announced the US Food and Drug Administration (FDA) has granted Breakthrough Device designation for a laser-assisted inferior vena cava (IVC) filter...
VTE-related factors and elevated bleeding risk associated with IVC filter placement...
In a recent study, factors related with venous thromboembolism (VTE) severity—including pulmonary embolism response team (PERT) referral from the intensive care unit (ICU) and...
Society of Interventional Radiology publishes IVC filter guidelines
The Society of Interventional Radiology (SIR) recently published new clinical practice guidelines that provide evidence-based recommendations on the use of inferior vena cava (IVC)...
No difference in PE incidence between patients treated with IVC filters...
In a case-control study of patients with perceived contraindications to anticoagulation, who either received or did not receive inferior vena cava (IVC) filters, no...
Argon Medical announces launch of two new IVC filter retrieval kits
Argon Medical Devices has announced the commercial launch of its Single-loop and Triple-loop retrieval kits for sale in the USA. The Single-loop and Triple-loop...
BTG acquires Novate Medical
BTG has announced it has acquired Novate Medical, a medical device company focused on the prevention of pulmonary embolism in patients at high risk...
One-year SENTRY trial data offer a “a new perspective” on IVC...
Twelve-month results from the SENTRY trial evaluating the Sentry bioconvertible inferior vena cava (IVC) filter (Novate) have shown a 0% rate of symptomatic pulmonary...